What does high PSA (Prostate-specific Antigen) mean?

High PSA levels can indicate prostate conditions ranging from benign enlargement to cancer, but many factors affect PSA including age, medications, and recent activities. While PSA above 4.0 ng/mL is traditionally considered elevated, interpretation requires considering individual factors and often additional testing.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding PSA and Its Role in Prostate Health

Prostate-specific antigen (PSA) is a protein produced by cells in the prostate gland, a small walnut-sized organ that sits below the bladder in men. Both normal and cancerous prostate cells produce PSA, which enters the bloodstream in small amounts. When PSA levels rise above typical ranges, it can signal various prostate conditions, though not necessarily cancer.

PSA testing has become a cornerstone of men's health screening, particularly for those over 50. However, interpreting PSA results requires nuance and consideration of multiple factors. Understanding what constitutes a high PSA level and what it might mean for your health is crucial for making informed decisions about further testing and treatment.

What PSA Levels Are Considered High?

Traditionally, a PSA level above 4.0 nanograms per milliliter (ng/mL) has been considered elevated. However, this one-size-fits-all threshold has evolved as research has shown that normal PSA levels vary significantly based on age, race, and individual factors. Many experts now use age-adjusted ranges to better assess whether a PSA level is concerning.

PSA Level Interpretation and Cancer Risk

PSA Level (ng/mL)Cancer RiskCommon CausesTypical Next Steps
0-4.00-4.0Low (15%)Normal aging, mild BPHRoutine monitoring
4.1-10.04.1-10.0Moderate (25%)BPH, prostatitis, early cancerRepeat test, consider free PSA
10.1-20.010.1-20.0High (50-65%)Advanced BPH, cancerAdditional testing, possible biopsy
Above 20>20.0Very High (>70%)Cancer, severe prostatitisUrgent evaluation, imaging, biopsy

Cancer risk percentages are approximate and vary based on individual factors including age, race, and family history.

Age-Adjusted PSA Ranges

Research has established that PSA levels naturally increase with age as the prostate gland grows. Age-specific reference ranges help doctors better identify when PSA levels might indicate a problem rather than normal aging:

  • Men in their 40s: 0-2.5 ng/mL
  • Men in their 50s: 0-3.5 ng/mL
  • Men in their 60s: 0-4.5 ng/mL
  • Men 70 and older: 0-6.5 ng/mL

PSA Velocity and Density

Beyond absolute PSA levels, doctors also consider PSA velocity (how quickly PSA levels rise over time) and PSA density (PSA level relative to prostate size). A rapid increase in PSA, even within the normal range, may warrant investigation. Similarly, a higher PSA in a man with a smaller prostate might be more concerning than the same level in someone with an enlarged prostate.

Common Causes of Elevated PSA

While prostate cancer is often the primary concern with elevated PSA, numerous benign conditions and factors can cause PSA levels to rise. Understanding these causes helps put test results in context and reduces unnecessary anxiety.

Benign Prostatic Hyperplasia (BPH)

BPH, or enlarged prostate, is the most common cause of elevated PSA in older men. As men age, the prostate naturally grows larger, producing more PSA. This benign condition affects about 50% of men in their 50s and up to 90% of men over 80. BPH can cause urinary symptoms but is not cancerous and doesn't increase cancer risk.

Prostatitis

Inflammation or infection of the prostate, known as prostatitis, can cause significant PSA elevation. Acute bacterial prostatitis can cause PSA levels to spike dramatically, sometimes above 50 ng/mL, but levels typically return to normal after antibiotic treatment. Chronic prostatitis may cause more modest but persistent PSA elevation.

Recent Activities and Medical Procedures

Several activities and medical procedures can temporarily elevate PSA levels:

  • Ejaculation within 48 hours of testing
  • Vigorous exercise, particularly cycling
  • Digital rectal examination (DRE)
  • Prostate biopsy or surgery
  • Urinary catheter placement
  • Cystoscopy or other urological procedures

For accurate results, men should avoid these activities before PSA testing when possible, or inform their doctor if any have occurred recently.

When High PSA Might Indicate Prostate Cancer

While elevated PSA doesn't automatically mean cancer, certain patterns and levels increase suspicion. PSA levels above 10 ng/mL carry a greater than 50% chance of prostate cancer, while levels above 20 ng/mL suggest a high likelihood of cancer that may have spread beyond the prostate. However, even very high PSA levels can sometimes result from benign conditions.

Free vs. Total PSA

PSA exists in two forms in the blood: free PSA (unbound) and complexed PSA (bound to proteins). The ratio of free to total PSA can help distinguish between cancer and benign conditions. A lower percentage of free PSA (less than 10-15%) suggests a higher likelihood of cancer, while a higher percentage (above 25%) more likely indicates benign conditions.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Next Steps After a High PSA Result

A single elevated PSA result rarely leads directly to a cancer diagnosis. Instead, it typically triggers a series of steps to determine the cause and appropriate management. Regular monitoring of PSA levels can help track changes over time and guide decision-making about your prostate health.

Repeat Testing

Because PSA levels can fluctuate, doctors often recommend repeating the test before pursuing further evaluation. This helps rule out temporary elevations and establishes a more reliable baseline. Some men may benefit from testing every few months to track PSA velocity.

Additional Diagnostic Tests

If PSA remains elevated, additional tests may include:

  • Digital rectal examination to feel for abnormalities
  • Free PSA test to calculate the free-to-total ratio
  • 4Kscore or PHI (Prostate Health Index) tests for better risk assessment
  • MRI of the prostate to identify suspicious areas
  • Prostate biopsy if cancer risk appears significant

Managing and Monitoring PSA Levels

For men with elevated PSA but no cancer diagnosis, active surveillance often becomes the management strategy. This involves regular PSA testing, typically every 3-6 months, along with periodic physical examinations. The frequency depends on the PSA level, rate of change, and other risk factors.

Lifestyle Factors That May Affect PSA

While research is ongoing, some lifestyle modifications may help maintain healthy PSA levels:

  • Maintaining a healthy weight through diet and exercise
  • Limiting red meat and high-fat dairy consumption
  • Increasing intake of tomatoes (lycopene) and cruciferous vegetables
  • Managing stress through relaxation techniques
  • Avoiding smoking and excessive alcohol consumption

Medications That Affect PSA

Certain medications can lower PSA levels, potentially masking elevations. Finasteride and dutasteride, used for BPH and hair loss, typically reduce PSA by about 50%. Men taking these medications need their PSA values adjusted accordingly. Some supplements and herbal remedies may also affect PSA levels, so discussing all medications with your doctor is important.

Making Informed Decisions About PSA Testing

PSA screening remains controversial because it can lead to overdiagnosis and overtreatment of slow-growing cancers that might never cause symptoms. However, it can also detect aggressive cancers early when treatment is most effective. The decision to undergo PSA testing should involve a discussion with your healthcare provider about your individual risk factors, including age, family history, race, and overall health status.

Understanding what high PSA means empowers men to make informed decisions about their health. While elevated PSA warrants attention and follow-up, it's important to remember that most men with high PSA don't have prostate cancer. Working closely with healthcare providers to interpret results in context and develop an appropriate monitoring or treatment plan ensures the best outcomes for prostate health.

References

  1. Catalona, W. J., et al. (2023). Prostate cancer screening: Current status and future perspectives. Nature Reviews Urology, 20(4), 205-218.[Link][DOI]
  2. Loeb, S., & Catalona, W. J. (2022). The Prostate Health Index: A new test for the detection of prostate cancer. Therapeutic Advances in Urology, 14, 1-12.[PubMed][DOI]
  3. American Urological Association. (2023). Early Detection of Prostate Cancer: AUA Guideline. Journal of Urology, 210(1), 46-53.[Link][DOI]
  4. Vickers, A. J., et al. (2021). PSA velocity and doubling time in diagnosis and prognosis of prostate cancer. British Journal of Medical and Surgical Urology, 14(3), 126-133.[PubMed][DOI]
  5. National Cancer Institute. (2023). Prostate-Specific Antigen (PSA) Test. National Institutes of Health.[Link]
  6. Thompson, I. M., et al. (2022). Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA, 327(18), 1792-1800.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my PSA at home?

You can test your PSA at home with SiPhox Health's Hormone Focus Program, which includes PSA testing along with other key hormone biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home with testing available monthly, quarterly, or every 6 months.

What is the normal PSA range for my age?

Normal PSA ranges vary by age: 40s (0-2.5 ng/mL), 50s (0-3.5 ng/mL), 60s (0-4.5 ng/mL), and 70+ (0-6.5 ng/mL). However, individual factors like prostate size, medications, and recent activities can affect what's normal for you.

Can PSA levels go down on their own?

Yes, PSA levels can decrease naturally, especially if the elevation was due to temporary factors like recent ejaculation, exercise, or mild prostate inflammation. However, persistently elevated PSA typically requires medical evaluation to determine the underlying cause.

Should I avoid certain activities before a PSA test?

Yes, avoid ejaculation for 48 hours, vigorous exercise (especially cycling) for 48 hours, and schedule the test before any prostate examination or procedure. These activities can temporarily elevate PSA and affect test accuracy.

Does high PSA always mean cancer?

No, high PSA doesn't always indicate cancer. Common benign causes include enlarged prostate (BPH), prostate inflammation, urinary tract infections, and recent sexual activity. Only about 25% of men with PSA between 4-10 ng/mL have prostate cancer.

How often should I check my PSA if it's elevated?

If your PSA is elevated, most doctors recommend retesting in 1-3 months to confirm the result, then every 3-6 months for monitoring. The exact frequency depends on your PSA level, rate of change, and other risk factors.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details